Halozyme Appoints David Ramsay as Interim Chief Financial Officer
Go back to Halozyme Appoints David Ramsay as Interim Chief Financial Officer| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 77.01 -1.26 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.27 | 52 Week High | $18.39 | |||
| Open | $78.47 | 52 Week Low | $6.96 | |||
| Day High | $78.50 | P/E | N/A | |||
| Day Low | $75.71 | EPS | $-0.58 | |||
| Volume | 1,782,030 | |||||
